JWM
RDY icon

Janiczek Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Janiczek Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$626K Buy
41,055
+10,170
+33% +$146K 0.13% 67
2024
Q1 		$453K Buy
30,885
+8,700
+39% +$127K 0.1% 92
2023
Q4 		$309K Buy
22,185
+3,425
+18% +$45.8K 0.07% 109
2023
Q3 		$251K Buy
18,760
+1,800
+11% +$24.4K 0.07% 123
2023
Q2 		$214K Buy
16,960
+1,650
+11% +$19.3K 0.06% 124
2023
Q1 		$184K Buy
15,310
+1,320
+9% +$14.2K 0.05% 124
2022
Q4 		$149K Buy
13,990
+1,010
+8% +$10.9K 0.04% 161
2022
Q3 		$136K Buy
12,980
+4,400
+51% +$46.9K 0.04% 149
2022
Q2 		$88K Sell
8,580
-1,705
-17% -$18.5K 0.03% 218
2022
Q1 		$115K Buy
10,285
+5,065
+97% +$57.4K 0.03% 188
2021
Q4 		$68K Buy
5,220
+1,585
+44% +$20K 0.02% 259
2021
Q3 		$47K Sell
3,635
-595
-14% -$7.93K 0.02% 296
2021
Q2 		$62K Buy
4,230
+1,035
+32% +$14.5K 0.02% 216
2021
Q1 		$39K Buy
3,195
+1,140
+55% +$14.6K 0.02% 276
2020
Q4 		$29K Buy
2,055
+1,335
+185% +$18K 0.01% 289
2020
Q3 		$10K Buy
+720
New +$8.58K 0.01% 243

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janiczek Wealth Management's RDY Position: Q2 2024 in Review

Janiczek Wealth Management increased its Dr. Reddy's Laboratories (RDY) stake by 33% in Q2 2024, buying an estimated $146K and bringing the position to 41,055 shares worth $626K. The position accounts for 0.13% of the portfolio, ranked #67.

Janiczek Wealth Management first reported a position in RDY in Q3 2020 and has held it in 16 quarters since. 221 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Janiczek Wealth Management held 41,055 shares of Dr. Reddy's Laboratories worth $626K as of Q2 2024.
  • Janiczek Wealth Management bought 10,170 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $146K.
  • Dr. Reddy's Laboratories made up 0.13% of Janiczek Wealth Management's portfolio in Q2 2024, its #67 holding.
  • Janiczek Wealth Management first reported a position in Dr. Reddy's Laboratories in Q3 2020 and has held it in 16 quarters since.
  • 221 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.